bromocriptine has been researched along with Depression, Endogenous in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (44.12) | 18.7374 |
1990's | 12 (35.29) | 18.2507 |
2000's | 7 (20.59) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brambilla, F; Delsignore, R; Gardini, S; Gerra, G; Giusti, F; Laviola, G; Macchia, T; Moi, G; Zaimovic, A | 1 |
Bagheri, H; Montastruc, JL; Schmitt, L | 1 |
Au-Yeung, KM; Chan, KH; Cheng, TS; Cheung, RT; Ho, SL; Mak, W | 1 |
Willner, P | 1 |
Silverstone, T | 1 |
Abbruzzese, G; Albano, C; Loeb, DC; Roccatagliata, G | 1 |
Bertilsson, L; Nordin, C; Siwers, B | 1 |
Abensour, P; Agid, Y; Bonnet, AM; Jouvent, R; Lhermitte, F; Widlocher, D | 1 |
Gerlach, J; Waehrens, J | 1 |
Brosch, H; Fischer, EK; Fischer-Cornelssen, K; Petrovic, D; Theohar, C | 1 |
Julien, J | 1 |
Demel, I; Fleischhacker, WW; Schubert, H | 1 |
Klawans, HL | 1 |
Bouras, N; Bridges, PK | 1 |
Klein, DF; McGrath, PJ; Quitkin, FM | 1 |
Campbell, JL; Dale, TM; Lacoursiere, RB; Landon, JF; Liskow, BI; Nickel, EJ; Penick, EC; Powell, BJ; Samuelson, SD; Thomas, HM | 1 |
Cohen, AJ | 1 |
Krupina, NA; Kryzhanovskiĭ, GN; Orlova, IN | 1 |
Denda, K; Inoue, T; Kasahara, T; Koyama, T; Miura, J; Sakakibara, S; Tsuchiya, K | 1 |
Albert, R; Ebert, D; Hammon, G; May, A; Merz, A; Strasser, B | 1 |
Graham, JM; Grünewald, RA; Sagar, HJ | 1 |
Iordanskaia, TE; Krupina, NA; Kryzhanovskiĭ, GN; Orlova, IN | 2 |
Golbert, L; Micheletto, C; Oliveira, MC; Pizarro, CB | 1 |
Bencomo, L; Bhatia, SC; Bhatia, SK | 1 |
Aoshima, T; Kanno, M; Otani, K; Wada, T | 1 |
Colonna, L; Lepine, JP; Petit, M | 1 |
Muscat, R; Papp, M; Willner, P | 1 |
Bauer, LO; Kranzler, HR | 1 |
Becker, H; Bittkau, S; Przuntek, H; Schröder, J; Sczesni, B; Truong, DD; von Baumgarten, F | 1 |
Cohen, MJ; Holroyd, S | 1 |
Cookson, JC | 1 |
Cummings, JL; Friedenberg, DL | 1 |
Bernstein, J; Buckman, MT; Kellner, R; Mattox, JH; Pathak, D | 1 |
3 review(s) available for bromocriptine and Depression, Endogenous
Article | Year |
---|---|
[Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
Topics: Antidepressive Agents; Antiparkinson Agents; Bromocriptine; Citalopram; Depressive Disorder; Dopamine Agents; Female; Fluoxetine; Gambling; Humans; Levodopa; Middle Aged; Parkinson Disease | 2003 |
Dopamine and depression: a review of recent evidence. I. Empirical studies.
Topics: Amphetamine; Antipsychotic Agents; Brain; Bromocriptine; Depressive Disorder; Dihydroxyphenylalanine; Dopamine; Double-Blind Method; Homovanillic Acid; Humans; Norepinephrine; Parkinson Disease; Piribedil; Receptors, Dopamine; Research | 1983 |
Drug treatment of bipolar depression and mania.
Topics: Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Bromocriptine; Carbamazepine; Cholinesterase Inhibitors; Clonidine; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Humans; Lithium; Monoamine Oxidase Inhibitors; Phosphatidylcholines; Tryptophan; Valproic Acid; Verapamil | 1985 |
6 trial(s) available for bromocriptine and Depression, Endogenous
Article | Year |
---|---|
Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans.
Topics: Adolescent; Adult; Aggression; Bromocriptine; Depressive Disorder; Dopamine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Hallucinogens; Human Growth Hormone; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Personality; Personality Tests; Prolactin; Receptors, Dopamine D2; Substance-Related Disorders; Temperament | 2002 |
Bromocriptine and imipramine in endogenous depression. A double-blind controlled trial in out-patients.
Topics: Adolescent; Adult; Aged; Bromocriptine; Clinical Trials as Topic; Depressive Disorder; Dizziness; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Nausea; Outpatients; Psychiatric Status Rating Scales | 1981 |
A comparative, multicenter trial between bromocriptine and amitriptyline in the treatment of endogenous depression.
Topics: Adult; Amitriptyline; Bromocriptine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales | 1982 |
Bromocriptine in depression.
Topics: Adult; Bromocriptine; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male | 1982 |
A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders.
Topics: Adult; Alcoholism; Antisocial Personality Disorder; Anxiety Disorders; Bromocriptine; Comorbidity; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Nortriptyline; Personality Inventory; Psychiatric Status Rating Scales; Social Behavior; Veterans | 1995 |
Bromocriptine and cocaine cue reactivity in cocaine-dependent patients.
Topics: Adolescent; Adult; Bromocriptine; Cocaine; Depressive Disorder; Humans; Male; Personality Assessment; Placebo Effect; Psychiatric Status Rating Scales; Substance Abuse Detection; Substance Withdrawal Syndrome; Substance-Related Disorders; Videotape Recording | 1992 |
25 other study(ies) available for bromocriptine and Depression, Endogenous
Article | Year |
---|---|
Wilson's disease with depression and parkinsonism.
Topics: Adult; Antiparkinson Agents; Brain; Bromocriptine; Chelating Agents; Depressive Disorder; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Parkinsonian Disorders; Penicillamine; Suicide, Attempted; Tomography, X-Ray Computed; Trientine; Trihexyphenidyl | 2005 |
Response to bromocriptine distinguishes bipolar from unipolar depression.
Topics: Adult; Bipolar Disorder; Bromocriptine; Depressive Disorder; Diagnosis, Differential; Female; Humans; Male; Middle Aged | 1984 |
[Cerebrospinal HVA and 5-HIAA in patients with endogenous depression in the course of treatment].
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Bromocriptine; Depressive Disorder; Electroconvulsive Therapy; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Phenylacetates; Trazodone | 1980 |
Bromocriptine treatment of depressive disorders. Clinical and biochemical effects.
Topics: Adult; Aged; Bromocriptine; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales | 1981 |
Antiparkinsonian and antidepressant effects of high doses of bromocriptine. An independent comparison.
Topics: Adult; Aged; Bromocriptine; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Parkinson Disease | 1983 |
[Dementia syndrome in depressive states. Efficacy of bromocriptine therapy].
Topics: Bromocriptine; Dementia; Depressive Disorder; Female; Humans; Middle Aged | 1982 |
[Bromocriptin in organic depression (author's transl)].
Topics: Bromocriptine; Depressive Disorder; Electroencephalography; Female; Humans; Male; Middle Aged; Neurocognitive Disorders; Psychiatric Status Rating Scales | 1982 |
Behavioral alterations and the therapy of parkinsonism.
Topics: Bipolar Disorder; Bromocriptine; Dementia; Depressive Disorder; Humans; Levodopa; Mental Processes; Parkinson Disease; Psychoses, Substance-Induced | 1982 |
Bromocriptine treatment of relapses seen during selective serotonin re-uptake inhibitor treatment of depression.
Topics: Adult; Aged; Bromocriptine; Depressive Disorder; Dopamine Agents; Female; Humans; Male; Middle Aged; Recurrence; Selective Serotonin Reuptake Inhibitors | 1995 |
Bromocriptine for prolactinoma-related dissociative disorder and depression.
Topics: Bromocriptine; Depressive Disorder; Dissociative Disorders; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Middle Aged; Neurocognitive Disorders; Pituitary Neoplasms; Prolactin; Prolactinoma | 1995 |
[The effect of parlodel on development of depressive syndrome in rats, caused by administering 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Bromocriptine; Depressive Disorder; Disease Models, Animal; Dopamine Agonists; Drinking Behavior; Male; MPTP Poisoning; Rats; Rats, Wistar; Receptors, Dopamine D2 | 1995 |
Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bromocriptine; Depressive Disorder; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Patient Admission; Personality Inventory; Treatment Outcome | 1996 |
Eye-blink rates and depression. Is the antidepressant effect of sleep deprivation mediated by the dopamine system?
Topics: Adult; Bromocriptine; Depressive Disorder; Dopamine; Eye Movements; Humans; Male; Middle Aged; Sleep Deprivation | 1996 |
Hallucinosis in idiopathic Parkinson's disease.
Topics: Aged; Bromocriptine; Cognition Disorders; Depressive Disorder; Dopamine Agonists; Female; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Psychomotor Disorders; Retrospective Studies; Severity of Illness Index; Time Factors | 1997 |
[Effect of parlodel on sleep-wakefulness cycle parameters in rats with experimental MPTP-induced depressive syndrome].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Bromocriptine; Depressive Disorder; Dopamine Agonists; Male; Rats; Rats, Wistar; Sleep, REM; Syndrome; Wakefulness | 1999 |
[Effect of parlodel on the electrical activity of the rat brain during experimental depressive syndrome].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antidepressive Agents; Brain; Bromocriptine; Caudate Nucleus; Depressive Disorder; Dopamine Agents; Dopamine Agonists; Electroencephalography; Hippocampus; Male; Putamen; Rats; Rats, Wistar; Syndrome | 2000 |
[Hyperprolactinemia and psychological disturbance].
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Bromocriptine; Case-Control Studies; Chi-Square Distribution; Depressive Disorder; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Interview, Psychological; Male; Mental Disorders; Middle Aged; Psychiatric Status Rating Scales; Risk Factors | 2000 |
Effective treatment of venlafaxine-induced noncyclical mastalgia with bromocriptine.
Topics: Antidepressive Agents, Second-Generation; Breast Diseases; Bromocriptine; Cyclohexanols; Depressive Disorder; Dopamine Agonists; Female; Humans; Middle Aged; Pain; Venlafaxine Hydrochloride | 2000 |
Dose-dependent augmentation effect of bromocriptine in a case with refractory depression.
Topics: Bromocriptine; Depressive Disorder; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Lithium; Middle Aged; Triiodothyronine | 2001 |
Bromocriptine in affective disorders. A pilot study.
Topics: Affective Disorders, Psychotic; Aged; Bipolar Disorder; Bromocriptine; Depressive Disorder; Female; Humans; Male; Middle Aged; Pilot Projects; Psychotic Disorders | 1979 |
Antidepressant-like effects of dopamine agonists in an animal model of depression.
Topics: Animals; Arousal; Brain; Bromocriptine; Depressive Disorder; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Drinking; Ergolines; Helplessness, Learned; Male; Motivation; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Taste | 1992 |
[Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Depressive Disorder; Diazepam; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Lisuride; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia | 1991 |
Treatment of hyperprolactinemia in major depression.
Topics: Adult; Bromocriptine; Depressive Disorder; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Prolactinoma | 1990 |
Parkinson's disease, depression, and the on-off phenomenon.
Topics: Bromocriptine; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease | 1989 |
Dopamine agonists for reducing depression associated with hyperprolactinemia.
Topics: Analysis of Variance; Bromocriptine; Depression; Depressive Disorder; Drug Evaluation; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Prolactin | 1986 |